Zydus and Synthon to Commercialise Novel 505(B)(2) Oncology Product in US
Under the terms of this agreement, Synthon will be responsible for the development, manufacturing and supply of the finished product.
Commercialization | 13/02/2025 | By Aishwarya
Cipla Extends its Investment in Achira to Advance in PoC Diagnostic
Cipla Ltd. has signed definitive agreements for further investment of up to INR 26 crore in Optionally Convertible Preference Shares of Achira Labs Pvt. Ltd., in four tranches, subject to completion of certain milestones.
Commercialization | 16/05/2024 | By Aishwarya | 112
Biocon Signs Exclusive Licensing and Supply Deal with Biomm for Drug Commercialization
Biocon Limited has signed an exclusive licensing and supply agreement with Biomm to commercialize its vertically integrated drug product, Semaglutide (gOzempic).
Commercialization | 19/04/2024 | By Aishwarya | 102
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy